Locations:
Search
Multidisciplinary treatment of rare and complex immunodeficiencies
The potential for safer therapies
Patient reported outcomes differentiate between remission and low disease activity in PsA
Prevention of progression and complications is the primary goal
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A unique approach provides long-lasting results with minimal impact on the disease state
A broad differential diagnosis
Results of the largest population-based study to date
Scientific evidence for and clinical experience of using JAK inhibitors in the treatment of COVID-19
Case-control study assesses risk factors that play a role in tumor necrosis factor-α inhibitor-induced psoriasis
Clinical features that should make clinicians suspect vasculopathy
Advertisement
Advertisement